Lewis Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Buy
14,741
+31
+0.2% +$7.22K 1.31% 17
2026
Q1
$3.6M Sell
14,710
-498
-3% -$116K 1.47% 15
2025
Q4
$3.15M Buy
15,208
+223
+1% +$44.1K 1.28% 16
2025
Q3
$2.78M Buy
14,985
+1,015
+7% +$174K 1.14% 18
2025
Q2
$2.13M Buy
13,970
+8,783
+169% +$1.35M 1% 25
2025
Q1
$860K Buy
5,187
+298
+6% +$46.6K 0.71% 36
2024
Q4
$707K Buy
4,889
+282
+6% +$43.7K 0.54% 44
2024
Q3
$747K Buy
4,607
+323
+8% +$51.5K 0.54% 44
2024
Q2
$626K Buy
4,284
+91
+2% +$13.5K 0.48% 48
2024
Q1
$663K Sell
4,193
-25
-0.6% -$3.98K 0.55% 43
2023
Q4
$661K Buy
+4,218
New +$647K 0.61% 39

Other funds holding JNJ

Lewis Asset Management's JNJ Position: Q2 2026 in Review

Lewis Asset Management increased its Johnson & Johnson (JNJ) stake by 0.21% in Q2 2026, buying an estimated $7.22K and bringing the position to 14,741 shares worth $3.74M. The position accounts for 1.31% of the portfolio, ranked #17.

Lewis Asset Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,262 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lewis Asset Management held 14,741 shares of Johnson & Johnson worth $3.74M as of Q2 2026.
  • Lewis Asset Management bought 31 Johnson & Johnson shares in Q2 2026, an estimated $7.22K.
  • Johnson & Johnson made up 1.31% of Lewis Asset Management's portfolio in Q2 2026, its #17 holding.
  • Lewis Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,262 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lewis Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.